Reirradiation for Locoregional Recurrent Breast Cancer

医学 不良事件通用术语标准 四分位间距 不利影响 乳腺癌 放射治疗 核医学 癌症 内科学
作者
Sayeh Fattahi,Safia K. Ahmed,Sean S. Park,Ivy A. Petersen,Dean A. Shumway,Bradley J. Stish,Elizabeth Yan,Nicholas B. Remmes,Robert W. Mutter,Kimberly S. Corbin
出处
期刊:Advances in radiation oncology [Elsevier BV]
卷期号:6 (1): 100640-100640 被引量:37
标识
DOI:10.1016/j.adro.2020.100640
摘要

Reirradiation poses a distinct therapeutic challenge owing to risks associated with exceeding normal tissue tolerances and possibly more therapeutically resistant disease biology. We report our experience with reirradiation for locoregional recurrent or second primary breast cancer.Between 1999 and 2019, all patients with breast cancer treated with repeat breast/chest wall radiation therapy (RT) at our institution were identified. Adverse events were assessed using the Common Terminology Criteria for Adverse Events v5.0. Fisher exact, Mann-Whitney rank-sum, and unpaired t tests were used for statistical analysis. Freedom from locoregional recurrence and distant metastasis as well as overall survival were calculated using the Kaplan-Meier method.Seventy-two patients underwent reirradiation. Median prior RT dose, reirradiation dose, and cumulative dose were 60 Gy (interquartile range [IQR], 50-60.4 Gy), 45 Gy (IQR, 40-50 Gy), and 103.54 Gy2 (IQR, 95.04-109.62 Gy2), respectively. Median time between RT courses was 73 months (IQR, 29-129 months). Thirty-four patients (47%) had gross residual disease at time of reirradiation. Course intent was described as curative in 44 patients (61%) and palliative in 28 (39%). Fifty-two patients (72%) were treated with photons ± electrons and 20 (28%) with protons. With a median follow-up of 22 months (IQR, 10-43 months), grade 3 adverse events were experienced by 13% of patients (10% acute skin toxicity and 3% late skin necrosis). Time between RT courses and reirradiation fields was significantly associated with the development of grade 3 toxicity at any point. Proton therapy conferred a dosimetric advantage without difference in toxicity. At 2 years, locoregional recurrence-free survival was 74.6% and overall survival was 65.5% among all patients, and 93.1% and 76.8%, respectively, among curative intent patients treated without gross disease. Distant metastasis-free survival was 59.0% among all curative intent patients.Reirradiation for locoregional recurrent breast cancer is feasible with acceptable rates of toxicity. Disease control and survival are promising among curative intent reirradiation patients without gross disease.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
典雅葶发布了新的文献求助10
1秒前
1秒前
王赞完成签到,获得积分10
2秒前
Ysusb完成签到,获得积分10
3秒前
4秒前
4秒前
shinn发布了新的文献求助10
5秒前
cd发布了新的文献求助10
5秒前
6秒前
Luo发布了新的文献求助10
6秒前
量子星尘发布了新的文献求助10
8秒前
西瓜籽发布了新的文献求助10
8秒前
8秒前
15832369693发布了新的文献求助10
10秒前
10秒前
王梦豪发布了新的文献求助10
10秒前
10秒前
Luo关闭了Luo文献求助
11秒前
33完成签到,获得积分20
13秒前
zpl发布了新的文献求助10
14秒前
沉默网络完成签到 ,获得积分10
14秒前
科目三应助动听幻儿采纳,获得10
15秒前
16秒前
16秒前
17秒前
ldjack发布了新的文献求助10
20秒前
123456发布了新的文献求助10
20秒前
十一发布了新的文献求助10
21秒前
yanyifan完成签到,获得积分10
21秒前
盖世英雄完成签到,获得积分10
22秒前
22秒前
23秒前
欢呼吐司完成签到,获得积分10
24秒前
xiaoqi发布了新的文献求助10
24秒前
24秒前
26秒前
26秒前
chufan完成签到,获得积分10
27秒前
Bio应助Yurrrrt采纳,获得50
27秒前
27秒前
高分求助中
Picture Books with Same-sex Parented Families: Unintentional Censorship 700
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
Effective Learning and Mental Wellbeing 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3975250
求助须知:如何正确求助?哪些是违规求助? 3519625
关于积分的说明 11199055
捐赠科研通 3255962
什么是DOI,文献DOI怎么找? 1798001
邀请新用户注册赠送积分活动 877358
科研通“疑难数据库(出版商)”最低求助积分说明 806298